A bill to provide for the issuance of an Alzheimer's Disease Research Semipostal Stamp.

Bill: 115-s-2208
Sponsor: full_name: Sen. Markey, Edward J. [D-MA]
Introduced: 2017-12-07
Policy area: Government Operations and Politics
Subjects: Aging

Health programs administration and funding

Medical research

Neurological disorders

Postal service

Research administration and funding
Latest action: action_date: 2017-12-07
text: Read twice and referred to the Committee on Homeland Security and Governmental Affairs.

Summaries:
action_date: 2017-12-07
action_desc: Introduced in Senate
text: <p>This bill directs the U.S. Postal Service to issue and sell an Alzheimer's Disease Research Semipostal Stamp.</p> <p>Proceeds from the sale of the stamp must be transferred to the National Institutes of Health for medical research relating to Alzheimer's disease.</p> <p>The stamp must be made available to the public for six years. </p> <p>Any limitation relating to whether more than one semipostal stamp may be offered for sale at the same time shall not apply to the stamp issued under this bill. </p>

tv_txt: II 115th CONGRESS 1st Session S. 2208 IN THE SENATE OF THE UNITED STATES December 7, 2017 Mr. Markey (for himself, Ms. Collins , Mrs. Capito , and Mr. Van Hollen ) introduced the following bill; which was read twice and referred to the Committee on Homeland Security and Governmental Affairs A BILL To provide for the issuance of an Alzheimer's Disease Research Semipostal Stamp.

1. Alzheimer's Disease Research Se­mi­post­al Stamp (a) Definition In this section, the term se­mi­post­al stamp has the meaning given the term se­mi­post­al in section 416(a)(1) of title 39, United States Code. (b) Issuance In order to afford a convenient way for members of the public to contribute to funding for medical research relating to Alzheimer's disease, the United States Postal Service shall issue a semipostal stamp (referred to in this section as the Alzheimer's Disease Research Semipostal Stamp ) in accordance with subsection (c). (c) Terms and conditions (1) In general Except as provided in this subsection, the issuance and sale of the Alzheimer's Disease Research Semipostal Stamp shall be governed by section 416 of title 39, United States Code, and regulations issued under that section. (2) Duration The Alzheimer's Disease Research Semipostal Stamp shall be made available to the public for a period of 6 years, beginning not later than 1 year after the date of enactment of this Act. (3) Disposition of proceeds All amounts becoming available from the sale of the Alzheimer's Disease Research Semipostal Stamp (as determined under section 416(d) of title 39, United States Code) shall be transferred to the National Institutes of Health, for the purpose described in subsection (b), through payments which shall be made not less frequently than 2 times a year. (4) Limitation For purposes of section 416 of title 39, United States Code (including any regulation prescribed under subsection (e)(1)(C) of that section), the semipostal stamp issued under this section shall not apply to any limitation relating to whether more than 1 semipostal stamp may be offered for sale at the same time.